Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Honoki, K.
Right arrow Articles by Konishi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honoki, K.
Right arrow Articles by Konishi, Y.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Bone Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Possible Involvement of bcl-2 Suppression in Wild-Type p53 Gene-Dependent Cell Growth Repression in Rat Osteosarcoma Cells

Kanya Honoki

Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan

Toshifumi Tsujiuchi

Department of Oncological Pathology, Nara Medical University, Kashihara, Nara, Japan

Masahiro Tsutsumi

Department of Oncological Pathology, Nara Medical University, Kashihara, Nara, Japan

Akira Kido

Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan

Toru Morishita

Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan

Masatoshi Yoshimoto

Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan

Yoshizumi Miyauchi

Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan

Yoshio Mii

Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan

Susumu Tamai

Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan

Yoichi Konishi

Department of Oncological Pathology, Nara Medical University, Kashihara, Nara, Japan

We recently obtained 3 cloned cell lines demonstrating the p53 mutation from a lung metastatic nodule of a rat transplantable osteosarcoma. In this study, we applied wild-type p53 gene transfer to the rat osteosarcoma cells by lipofection to investigate the effects on cell growth, expression of genes such as waf1/p21, bcl-2, and bax, and nucleosomal DNA fragmentation due to apoptosis. Reconstitution of the p53 gene inhibits cellular growth, and this growth-suppressive effect is partly due to apoptosis involving bcl-2 gene suppression in this tumor type. This rat osteosarcoma model is similar in biologic behavior to human cases and thus is very suitable for further investigation of tumorigenesis and gene therapy for osteosarcoma.

Key Words: Osteosarcoma • rat • p53 • waf1/p21 • bcl-2 • bax • apoptosis

References

  • Berges RR, Furuya Y., Remington L., English HF, Jacks T., Isaacs JT (1993). Cell proliferation, DNA repair, and p53 function are not required for programmed cell death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 90: 8910-8914.[Abstract/Free Full Text]
  • Chiou SK, Rao L., White E. (1994). Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14: 2556-2563.[Abstract/Free Full Text]
  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Myllie AH (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.[CrossRef][Medline] [Order article via Infotrieve]
  • Dahlin DC, Coventry MB (1967). Osteogenic sarcoma: A study of six hundred cases. J Bone Joint Surg 49: 101-110.[Abstract/Free Full Text]
  • Diller L., Kassel J., Nelson CE, Gryka MA, Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker SJ, Vogelstein B., Friend SH (1990). p53 function as a cell cycle protein in osteosarcoma. Mol Cell Biol 10: 5772-5781.[Abstract/Free Full Text]
  • Finley CA, Hinds PW, Levine AJ (1989). The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-1093.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fujiwara T., Cai DW, Georges RN, Mukhopadhyay T., Grimm EA, Roth JA ( 1994). Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst 86: 1458-1462.[Abstract/Free Full Text]
  • Ginsberg D., Michael MD, Ginsberg D., Oren M. ( 1991). Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of protein. Mol Cell Biol 11: 582-585.[Abstract/Free Full Text]
  • Hollstein M., Sidransky D., Vogelstein B., Harris CC (1991). p53 mutations in human cancers. Science 253: 49-53.[Abstract/Free Full Text]
  • Honoki K., Mori T., Tsutsumi M., Tsujiuchi T., Kido A., Morishita T., Miyauchi Y., Dohi Y., Mii Y., Tamai S., Konishi Y. (1998). Heterogeneous pattern of gene expression in cloned cell lines established from a rat transplantable osteosarcoma lung metastatic nodule. Cancer Lett 127: 221-228.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Honoki K., Tsutsumi M., Miyauchi, Y., Mii Y., Tsujiuchi T., Morishita T., Miura S., Aoki M., Kobayashi E., Tamai S., Konishi Y. (1993). Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas. Cancer Res 53: 5038-5042.[Abstract/Free Full Text]
  • Kastan MB, Zhan Q., el-Deiry WS, Carrier F., Jacks T., Walsh WV, Plunkett BS, Vogelstein B., Fornace AJ (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-teleangiectasia. Cell 71: 587-597.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kido A., Tsujiuchi T., Tsutsumi M., Takahama M., Okajima E., Kobitsu K., Miyauchi Y., Mii Y., Tamai S., Konishi Y. (1997). p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats. Cancer Lett 112: 5-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.[CrossRef][Medline] [Order article via Infotrieve]
  • Marcellus RC, Teodoro JG. Charbonneau R., Shore G., Branton PE (1996) Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B 55 kDa protein. Cell Growth Differ 7: 1643-1650.[Abstract]
  • Mii Y., Tsutsumi M., Shiraiwa K., Miyauchi Y., Honoki K., Maruyama H., Ohgushi H., Masuhara K., Konishi Y. (1988). Transplantable osteosarcomas with high lung metastatic potential in Fischer 344 rats. Jpn J Cancer Res 79: 589-592.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Miyashita T., Harigai M., Hanada M., Reed JC (1994). Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135.[Abstract/Free Full Text]
  • Miyashita T., Krajewski S., Krajewska M., Wang HG, Lin HK, Liebermann DA, Hoffman B., Reed JC (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.[Web of Science][Medline] [Order article via Infotrieve]
  • Miyasita T., Reed JC (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nigro JM, Baker SJ, Preisinger AC, et al (13 coauthors) (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708.[CrossRef][Medline] [Order article via Infotrieve]
  • Oltvai ZN, Milliman CL, Korsmeyer SJ (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Radinsky R., Fidler IJ, Price JE, Esumi N., Tsan R., Petty CM, Bucana CD, Bar-Eli M. (1994). Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 9: 1877-1883.[Web of Science][Medline] [Order article via Infotrieve]
  • Rao L., Debbas M., Sabbatini P., Hockenbery D., Korsmeyer S., White E. (1992). The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc Natl Acad Sci USA 89:7742-7746.[Abstract/Free Full Text]
  • Roth JA, Nguyen D., Lawrence DD, et al (21 coauthors) (1996). Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med 2: 985-991.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Selins KS, Cohen JJ (1987). Gene induction by {gamma}-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139: 3199-3206.[Abstract]
  • Shimamura A., Fisher DE (1996). p53 in life and death. Clin Cancer Res 2: 435-440.[Web of Science][Medline] [Order article via Infotrieve]
  • Sidransky D., Mikkelsen T., Schwechheimer K., Rosenblum ML, Cavanee W., Vogelstein B. (1992). Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846-847.[CrossRef][Medline] [Order article via Infotrieve]
  • Unni KK (1996). Dahlin's Bone Tumors, 5th ed. Lippincott and Raven, Philadelphia, pp 143-160.
  • Vogelstein B., Kinzler KW (1992). p53 function and dysfunction. Cell 70: 523-526.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wang J., Bucana CD, Roth JA, Zhang WW (1995). Apoptosis induced in human ostesarcoma cells is one of the mechanisms for cytocidal effect of Ad5CMV-p53. Cancer Gene Ther 2: 9-17.[Medline] [Order article via Infotrieve]
  • Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. (1991). Wild type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6. Nature 352: 345-347.[CrossRef][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 28, No. 4, 575-579 (2000)
DOI: 10.1177/019262330002800411


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Honoki, K.
Right arrow Articles by Konishi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honoki, K.
Right arrow Articles by Konishi, Y.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Bone Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?